Mangalam Drugs & Organics Limited (NSE:MANGALAM)

Market Cap	511.41M -57.3%
Revenue (ttm)	2.32B -22.2%
Net Income	-382.41M
EPS	-24.16
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	33,869
Open	32.64
Previous Close	32.32
Day's Range	31.42 - 32.64
52-Week Range	22.80 - 75.55
Beta	0.30
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Mangalam Drugs & Organics

Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers active pharmaceutical ingredients (API) products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, etodolac, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, olanzapine, primaquine and piperaqui...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 319
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MANGALAM

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 24, 2026

Data Sources Report a data error